Warner Pharmaceutical Company's third quarterly report for 2021 showed that the company's main income was 806 million yuan, up 26.51% from the same period last year; the net profit was 103 million yuan, up 13.74% from the same period last year; and the non-net profit was 91.2072 million yuan, up 15.48% from the same period last year. Among them, in the third quarter of 2021, the company's main income in a single quarter was 287 million yuan, up 14.58% from the same period last year; net profit in a single quarter was 34.0944 million yuan, up 0.56% from the same period last year Non-net profit in a single quarter was 31.593 million yuan, up 9.47% from the same period last year; debt ratio 16.16%, investment income-1.0533 million yuan, financial expenses-2.4936 million yuan, gross profit margin 73.29%.
There are 10 new top 10 tradable shareholders in this period. Wang Qinhai holds 308329 shares, accounting for 1.61% of tradable shares, Tang Zuyi holds 155503 shares, accounting for 0.81% of tradable shares, Li Fuxing holds 118534 shares, accounting for 0.62% of tradable shares, Li Jinsong holds 89993 shares, accounting for 0.47% of tradable shares, Shen Xiaoyu holds 88,416 shares, accounting for 0.46% of tradable shares. Wan Haiyang holds 75503 shares, accounting for 0.39% of tradable shares, Cheng Yongzhong holds 256753 shares, accounting for 1.34% of tradable shares, Yuan Peiliang holds 120087 shares, accounting for 0.63% of tradable shares, Zhang Lunan holds 102431 shares, accounting for 0.54% of tradable shares, Yang Chun holds 93425 shares, accounting for 0.49% of tradable shares.
For a summary of the financial report data, please see the following figure:
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If there are any questions in the article, please contact us.